SCHEMBL6799443

SCHEMBL6799443

COc1ccc(C(C2CCCCC2)N(Cc2ccc(O)cc2)C(=O)Nc2c(C(C)C)cccc2C(C)C)nc1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.39
ALDH1A1 P00352 3/20 0.39
HTT P42858 2/20 0.38
YAP1 P46937 3/20 0.38
TEAD4 Q15561 3/20 0.38
UBE2M P61081 1/20 0.37
DCUN1D1 Q96GG9 1/20 0.37
LPAR1 Q92633 1/20 0.36
SOAT2 O75908 1/20 0.35
SOAT1 P35610 1/20 0.35
NPSR1 Q6W5P4 2/20 0.35
MITF O75030 1/20 0.35
MAPT P10636 1/20 0.35
PKM P14618 1/20 0.35
MAPK1 P28482 1/20 0.35
OPRK1 P41145 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6186318 0.86 SOAT1 (0.40) UBE2MDCUN1D1SOAT2SOAT1
SCHEMBL6183409 0.84 LPAR1 (0.43) UBE2MDCUN1D1LPAR1SOAT2SOAT1
SCHEMBL6804805 0.83 NMBR (0.38) UBE2MDCUN1D1SOAT2SOAT1MEN1
SCHEMBL6807668 0.82 UBE2M (0.38) UBE2MDCUN1D1SOAT2SOAT1MEN1
SCHEMBL6182579 0.81 SOAT1 (0.43) UBE2MDCUN1D1SOAT2SOAT1MEN1
SCHEMBL6184262 0.80 SOAT1 (0.40) UBE2MDCUN1D1SOAT2SOAT1MEN1
SCHEMBL6803558 0.78 UBE2M (0.39) UBE2MDCUN1D1
SCHEMBL6202947 0.78 MAPT (0.40) LMNAUBE2MDCUN1D1SOAT2SOAT1
SCHEMBL6183734 0.77 SOAT1 (0.38) UBE2MDCUN1D1SOAT2SOAT1MEN1
SCHEMBL6803822 0.77 SOAT2 (0.38) HTTUBE2MDCUN1D1SOAT2SOAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040063643-A1 Bombesin antagonists PFIZER INC. 2004-04-01 US claimed
US-20040063643-A1 Bombesin antagonists PFIZER INC. 2004-04-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040063643-A1 Bombesin antagonists BRS3, NPSR1, GNRHR LMNA 2660/4885ALDH1A1 3777/4885HTT 4402/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.